Certain Stock Options of Candel Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-JAN-2022. These Stock Options will be under lockup for 181 days starting from 26-JUL-2021 to 23-JAN-2022. Details: The executive officers, directors, and all of the holders of equity securities have entered into a lock up agreement pursuant to which, they will not to sell, offer, contract or grant any option to sell (including any short sale), pledge, transfer, establish an open “put equivalent position” within the meaning of Rule 16a-l(h) under the Securities Exchange Act of 1934, as amended; or otherwise dispose of any shares of common stock, options or warrants to acquire shares of common stock, or securities exchangeable or exercisable for or convertible into shares of common stock currently or hereafter owned either of record or beneficially; or publicly announce an intention to do any of the foregoing for a period of 180 days after the date of this prospectus without the prior written consent of the Jefferies LLC, Credit Suisse Securities (USA) LLC, BMO Capital Markets Corp. and UBS Securities LLC.